My following two posts are long because I’m trying to establish that Ryoncil is about a lot more than acute GvHD, the lead candidate of a precious acute platform. They're from the perspective of medical insurers who have a direct window onto the real world. I think this must be the most cynical jaded group who are surely aware that for a long time they’ve been paying out for marketing over substance.
IMO, it’s about more than acute GvHD. I’m looking mainly for evidence of Ryoncil as a prophylactic for chronic GvHD but beyond that.
We live in a world where the picture painted by statistics often doesn’t match reality. Please be aware the second post contains distressing details about chronic GVHD.
I have no doubt of a bad situation n IBD, especially pediatrics. I’m not advocating pestering doctors but if you get the opportunity to speak to a colorectal surgeon, ask them about the incidence of colectomies/resections since the advent of the “revolutionary” biologics.
- Forums
- ASX - By Stock
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
My following two posts are long because I’m trying to establish...
-
-
- There are more pages in this discussion • 535 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.09 |
Change
-0.050(4.39%) |
Mkt cap ! $1.244B |
Open | High | Low | Value | Volume |
$1.14 | $1.17 | $1.07 | $8.385M | 7.489M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8500 | $1.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.09 | 26954 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8500 | 1.080 |
8 | 57036 | 1.075 |
12 | 113080 | 1.070 |
6 | 49342 | 1.065 |
6 | 134320 | 1.060 |
Price($) | Vol. | No. |
---|---|---|
1.090 | 26954 | 3 |
1.095 | 71504 | 4 |
1.100 | 31504 | 2 |
1.105 | 31504 | 2 |
1.110 | 70692 | 5 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online